Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope

Plasticity of influenza virus hemagglutinin (HA) conformation increases an opportunity to generate conserved non-native epitopes with unknown functionality. Here, we have performed an in-depth analysis of human monoclonal antibodies against a stem-helix region that is occluded in native prefusion ye...

Full description

Saved in:
Bibliographic Details
Published inPLoS pathogens Vol. 19; no. 8; p. e1011554
Main Authors Tonouchi, Keisuke, Adachi, Yu, Suzuki, Tateki, Kuroda, Daisuke, Nishiyama, Ayae, Yumoto, Kohei, Takeyama, Haruko, Suzuki, Tadaki, Hashiguchi, Takao, Takahashi, Yoshimasa
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 09.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Plasticity of influenza virus hemagglutinin (HA) conformation increases an opportunity to generate conserved non-native epitopes with unknown functionality. Here, we have performed an in-depth analysis of human monoclonal antibodies against a stem-helix region that is occluded in native prefusion yet exposed in postfusion HA. A stem-helix antibody, LAH31, provided IgG Fc-dependent cross-group protection by targeting a stem-helix kinked loop epitope, with a unique structure emerging in the postfusion state. The structural analysis and molecular modeling revealed key contact sites responsible for the epitope specificity and cross-group breadth that relies on somatically mutated light chain. LAH31 was inaccessible to the native prefusion HA expressed on cell surface; however, it bound to the HA structure present on infected cells with functional linkage to the Fc-mediated clearance. Our study uncovers a novel non-native epitope that emerges in the postfusion HA state, highlighting the utility of this epitope for a broadly protective antigen design.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
KT, YA, and YT declare that an intellectual property application has been filed for the LAH31 antibody.
ISSN:1553-7374
1553-7366
1553-7374
DOI:10.1371/journal.ppat.1011554